The Dynamics of Human Atrial Fibrillation

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT05366361
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
22 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

Atrial fibrillation (AF) is an enormous public health problem in the United States, affecting 2-5 million Americans and causing rapid heart beats, stroke, heart failure or death. In this project, the applicant will develop a novel framework to better understand human AF that builds on agreement between several concepts for the disease. The applicant will develop strategies to identify AF patients who will best respond to each of several therapies, to guide personalized therapy.

Key Dates

Start date
Aug 18, 2020
Status verified
Feb 2026
Primary completion
Dec 30, 2026
Completion
Dec 30, 2027

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Patients Undergoing Clinically-Indicated Maze Surgery
    This group includes patients with persistent AF who will be undergoing clinically-indicated Maze surgery.
  • Arm: Patients Undergoing Clinically-Indicated Ablation
    This groups includes patients with persistent AF who will be undergoing clinically-indicated ablation.

Primary Outcome Measure

Does the Area of Organized Regions in AF predict success from Ablation? [ Time Frame: 1 year. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305
Sanjiv Narayan, MD
[email protected]
(650) 724-1850
Kathleen Mills, BA
[email protected]

Find similar trials in Stanford, CA

By condition
Atrial fibrillation
By specialty
CardiologyHeart disease
By research site
Stanford University· Stanford, CA

Related Studies